Rethinking screening for thyroid autoimmunity in vitiligo - 14/11/16
Doi : 10.1016/j.jaad.2016.04.029
Michael Liu, BS a, Elizabeth Murphy, MD, DPhil b, Erin Huiras Amerson, MD c, ⁎ 
a School of Medicine, University of California, San Francisco, California
b Department of Medicine, Division of Endocrinology, University of California, San Francisco, California
c Department of Dermatology, University of California, San Francisco, California
∗Reprint requests: Erin Huiras Amerson, MD, Department of Dermatology, University of California, San Francisco, 1701 Divisadero St, Third Floor, San Francisco, CA 94115.Department of DermatologyUniversity of California, San Francisco1701 Divisadero St, Third FloorSan FranciscoCA94115
Key words : antithyroid peroxidase antibody, autoimmune thyroid disease, best practice, Graves disease, Hashimoto thyroiditis guidelines, thyroid autoantibodies, thyroid-stimulating hormone, screening, vitiligo
Abbreviations used : AITD, TPOAb, TSH
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2016
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 75 - N° 6
P. 1278-1280 - dicembre 2016 Ritorno al numero
Articolo precedente
- Diffuse atrophic papules and plaques, intermittent abdominal pain, paresthesias, and cardiac abnormalities in a 55-year-old woman
- Brittany Oliver, Manfred Boehm, Douglas R. Rosing, Lee S. Shapiro, Daniel T. Dempsey, Peter A. Merkel, Chyi-Chia Richard Lee, Edward W. Cowen
- Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis
- Maxwell B. Sauder, Alana McEvoy, Michele Louise Ramien
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?